14
MRSA in the NL 010313 Andreas Voss, MD, PhD 1 EMRSA HAMRSA (HOCAMRSA, HOLAMRSA) CAMRSA (COHAMRSA, COLAMRSA) LAMRSA The only type I am interested in: IDCWYCIJTMHTFIMRSA* * I Don’t Care What You Call It – Just Tell Me How To Fix It – MRSA (ScoR Weese) CAMRSA HAMRSA LAMRSA CA HA LA “LiRle brother” “Main problem” “Giant trouble” CAMRSA HAMRSA LAMRSA

MRSA in the Netherlands

Embed Size (px)

DESCRIPTION

Talk at Singapore Infectious Diseases Society (SIDS) annual report

Citation preview

Page 1: MRSA in the Netherlands

MRSA  in  the  NL   01-­‐03-­‐13  

Andreas  Voss,    MD,  PhD   1  

¤ E-­‐MRSA  ¤ HA-­‐MRSA            (HO-­‐CA-­‐MRSA,  HO-­‐LA-­‐MRSA)  ¤ CA-­‐MRSA            (CO-­‐HA-­‐MRSA,  CO-­‐LA-­‐MRSA)  ¤ LA-­‐MRSA    

The  only  type  I  am  interested  in:  ¤ IDCWYCI-­‐JTMHTFI-­‐MRSA*  

*  I  Don’t  Care  What  You  Call  It  –  Just  Tell  Me  How  To  Fix  It  –  MRSA  (ScoR  Weese)  

CA-­‐MRSA                                                              HA-­‐MRSA                                                  LA-­‐MRSA      

CA  

HA  

LA  

“LiRle  brother”                                                “Main  problem”                                    “Giant  trouble”  CA-­‐MRSA                                                              HA-­‐MRSA                                                  LA-­‐MRSA      

Page 2: MRSA in the Netherlands

MRSA  in  the  NL   01-­‐03-­‐13  

Andreas  Voss,    MD,  PhD   2  

¤ ProspecXve  cohort  study  of  MRSA  infecXons  idenXfied  in  12  Minnesota  laboratories  in  2000  

¤ 1100  MRSA  infecXons  ² 131  (12%):  community-­‐associated  

² 937  (85%):  health  care-­‐associated  

¤ Epidemiological  definiXon    

Naimi et al. JAMA 2003; 290: 2976-84

CA-/HA-MRSA: Age Distribution!

Naimi et al. JAMA 2003; 290: 2976-84

No  underlying  condiXons  as  risk  factor  

Naimi et al. JAMA 2003; 290: 2976-84

CA-/HA-MRSA: Underlying conditions!

Predominantly  skin  and  soc  Xssue  infecXons  

CA-/HA-MRSA: Infection type!

Naimi et al. JAMA 2003; 290: 2976-84

Page 3: MRSA in the Netherlands

MRSA  in  the  NL   01-­‐03-­‐13  

Andreas  Voss,    MD,  PhD   3  

SXll  suscepXble  to  most  other  classes  of  anXbioXcs  

CA-/HA-MRSA: Susceptibility!

Naimi et al. JAMA 2003; 290: 2976-84

Enriched  with  SCCmec  IV,  PVL  and  other  exotoxins  

Naimi et al. JAMA 2003; 290: 2976-84

CA-­‐  strains  geneXcally  unrelated  to  HA-­‐MRSA  

CA-/HA-MRSA: Clonal spread!

¤ Aboriginals  ¤ NaXve  Americans  (indians,  eskimos)  ¤ Jails  ¤ Saunas  ¤ Sport  teams  ¤ Homosexual  men  ¤ Military  recruits  ¤ Day  Care  Centers  

King  et  al      Ann  Intern  Med    2006;144:309-­‐317      

" SSTI  caused  by  CO-­‐MRSA  in  a  non-­‐outbreak  se;ng    (Atlanta,  Q3+4  2003)  

" 384  persons  with  documented  CA-­‐SSTI  due  to  S.  aureus  

Page 4: MRSA in the Netherlands

MRSA  in  the  NL   01-­‐03-­‐13  

Andreas  Voss,    MD,  PhD   4  

King  et  al      Ann  Intern  Med    2006;144:309-­‐317      

nearly  ¾  MRSA  

nearly  90%  US  300/400*  

*  99%  (155  of  157)  of  the  typed  CA-­‐MRSA  isolates  were  USA  300  

¤ Aboriginals  ¤ NaXve  Americans  (indians,  eskimos)  ¤ Jails  ¤ Saunas  ¤ Sport  teams  ¤ Homosexual  men  ¤ Military  recruits  ¤ Day  Care  Centers  ¤ Animal  lovers  ?  

First  

cases  

•  2004:  23%  

•  2006:  50%  

•  2010:  >70%  

Page 5: MRSA in the Netherlands

MRSA  in  the  NL   01-­‐03-­‐13  

Andreas  Voss,    MD,  PhD   5  

•  50  farms/232  individuals  –  50  farmers,  13  employees  –  169  household  members  

 

•  Intensive  pig  contact  (29%),    medium  contact  (12%),    person  living  on  farm  (2%)  MRSA    

•  Higher  risk  with  sows  and  finishing  pigs  

P39      van  Cleef  et  al.  NVMM  2008      Van  Cleef  et  al.      Epidemiol  Infect    2010      doi:10.1017/S09502688100000245  

•  Three large pig slaughterhouses were studied in 2008 using ��� human and environmental samples.

•  The overall prevalence of nasal MRSA carriage in employees ��� of pig slaughterhouses was 5.6%

•  Working with live pigs was the single most important ��� factor for being MRSA positive (OR 38.2, P<0.0001).

•  Exact transmission routes from animals to humans remain to ��� be elucidated.

Graveland  et  al.  PLOSone  2010;  5:e10990  

¤ 15.9%  of  humans  in  contact  with  calves  were  MRSA+    ² 33%  of  the  farmers  (direct  contact)  ² 8%  of  the  family  members  

Graveland  et  al.    

Mulders  et  al.    Epidemiol  Infect  2010    doi:  10.1017/S095026881000000075  

•  40 Dutch broiler flocks, in six slaughterhouses and 466 personnel •  26 (5.6%) employees were positive •  Risk was significantly higher for personnel having contact with live ��� animals – especially hanging broilers on slaughterline (20.0%) vs all ��� other (1.9%). •  Conventional electric stunning = higher risk of MRSA carriage than ��� CO2 stunning (9.7% vs. 2.0%). •  From 40 Dutch slaughter flocks - 35.0% were positive. •  Of the 119 MRSA isolates, predominantly livestock-associated ��� MRSA ST398 was found, although 27.7% belonged to ST9 (spa type ��� t1430).

Page 6: MRSA in the Netherlands

MRSA  in  the  NL   01-­‐03-­‐13  

Andreas  Voss,    MD,  PhD   6  

¤  Randomly  selected  adults  (n=583)  from  3  Dutch  municipaliXes  in  high  pig-­‐desity  regions  

¤  Of  the  534  persons  without  livestock-­‐contact,  one  was  posiXve  for  MRSA  (0.2%).    

¤  Of  the  49  persons  who  did  indicate  to  be  working  at  or  living  on  a  livestock  farm,  13  were  posiXve  for  MRSA  (26.5%).  All  spa-­‐types  belonged  to  CC398.  

¤  LA-­‐MRSA  has  a  high  prevalence  in  people  with  direct  contact  with  animals.  At  this  moment  it  has  not  spread  from  the  farms  into  the  community.  

Use  of  anXmicrobials  in  food  animal  producXon  à    resistant  m.o.’s  and  resistance  genes  can  spread  from  

animals  to  humans  Kluytmans  JA      Clin  Microbiol  Infect    2010;16:11    

Buy two …

… get millions for free ! Kluytmans  JA      Clin  Microbiol  Infect    2010;16:11    

11.9%  

0

20

40

60

80

100

120

140

160

180

2002 2003 2004 2005 2006 2007 2008

ST398 unexpected

ST398

Other MRSA unexpected

other MRSA

Frequency  of  newly  idenXfied  MRSA  posiXve  individuals  increased  from  16/year  between  2002-­‐2006  to  148/year  between  2006-­‐2008  

930%  increase  of  which  81%  (108/132)  was  due  to  ST398      

Page 7: MRSA in the Netherlands

MRSA  in  the  NL   01-­‐03-­‐13  

Andreas  Voss,    MD,  PhD   7  

¤ More  cases  that  need  precauXons  and          isolaXon  

¤ More  HCWs  complaining  about  extra          work  

¤ Problems  of  isolaXon  ¤ “Destroy”  part  of  S&D  not  possible  with            permanent  source  

¤ What  to  do  with  MRSA+  HCWs?  

Nosocomial  transmission  of  ST398  MRSA  is  72%  less  likely  

Wassenberg  et  al.    Clin  Microbiol  Infect    2010   Wulf  et  al.    Eurosurveillance  2008;13  

Page 8: MRSA in the Netherlands

MRSA  in  the  NL   01-­‐03-­‐13  

Andreas  Voss,    MD,  PhD   8  

¤ EsXmated  “lower  virulence  than  HA-­‐MRSA”    

¤ Many  cases  of  skin  and  soc-­‐Xssue  infecXons          acer  direct  inoculaXon  (pig  bite  or  injuries          during  work)  

¤ Case  of  endocardiXs    

¤ Case  of  osteomyeliXs    

¤ Severe  wound  infecXons  

¤ InfecXon  acer  total  hip  replacement    

¤ …  cases  to  common  to  publish  

Van  Rijn  et  al.    P1951  

Ekkelenkamp  et  al.    Ned  Tijdschr  Geneesk    2006;150:2442-­‐7  

 Declercq    et  al.    Infec_on  2008  (epubl.)  

Page 9: MRSA in the Netherlands

MRSA  in  the  NL   01-­‐03-­‐13  

Andreas  Voss,    MD,  PhD   9  

MRSA bacteremia in Europe!

Source: EARSS report

¤ Search  &  Destroy  (Control)  strategy  to  avoid  introducXon  of  MRSA  into  health-­‐care  setngs  and  reduce  the  chance  of  transmission:    ² NaXonal  MRSA  guidelines  (WIP)  ² NaXonal  detecXon  methods  (NVMM)  ² Use  fast  and  reliable  detecXon  methods  

¤ IsolaXon  and  screening  of  risk-­‐paXents  on  admission  

² at  all  Xmes    

² colonized  and  infected  paXents  

¤ DecolonizaXon  of  MRSA  carriers  

¤ Consequent  acXons  when  transmissions  occur  

² screening  of  all  paXents  and  HCWs  at  risk  

² MRSA-­‐posiXve  HCWs  not  allowed  to  work      

¤ Placement  in  isolaXon  room  

² with  anteroom  and  negaXve  pressure  

¤ Gloves,  gowns  and  face-­‐masks    

² for  all  entering  the  room  

¤ Handhygiene  

Page 10: MRSA in the Netherlands

MRSA  in  the  NL   01-­‐03-­‐13  

Andreas  Voss,    MD,  PhD   10  

¤ IsolaXon  and  screening  of  risk-­‐paXents  on  admission  ² can’t  determine  paXents  at  risk  ² only  certain  departments!  

² not  when  too  busy/weekends  ² only  infected  paXents  

¤ No  decolonizaXon  of  MRSA  carriers  ¤ Non-­‐consequent  acXons  when  transmissions  occur  

² screening  of  all  paXents  but  not  HCWs    à  consequently  MRSA-­‐posiXve  HCWs  may  conXnue  to  spread    

0

200400

600

8001000

1200

1400

16001800

2000

Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2

2005 2006 2007 2008 2009

Counts of MRSA bacteraemia

Yea

r and

qua

rter

* DATA ARE PROVISIONAL NOT FOR WIDER CIRCULATION

BBC  World  news  

Courtesy: A. Pearson (HPA, Sept 2009)

MRSA  BSI    episodes  

V.  Jarlier  et  al.  Arch  Intern  Med  2010  

Page 11: MRSA in the Netherlands

MRSA  in  the  NL   01-­‐03-­‐13  

Andreas  Voss,    MD,  PhD   11  

¤ IsolaXon  IntervenXons  ¤ PromoXon  of  Hand  Hygiene  ¤ IdenXficaXon  of  paXents  with  MRSA    infecXons  or  colonizaXons  

¤ Feedback  ¤ Annual  reports  

IsolaXon  IntervenXons    ¤ Placement  of  paXents  with  MRSA  infecXons  or  colonizaXons  in  single-­‐bed  rooms  whenever  possible  

¤ Barrier  precauXons  for  paXents  with  MRSA  infecXons  or  colonizaXons  such  as:    ² disposable  gloves  worn  before  and  discarded  acer  paXent  contact  

² disposable  aprons  worn  for  extensive  contacts  (eg,  bed  making)  

² small  equipment  (eg,  stethoscope)  dedicated  to  the  paXent.  

Should  we  ask  universal  precauXons  ?  

PromoXon  of  Hand  Hygiene    

¤ Hand  washing  with  disinfectant  soap  acer  contact  with  paXents  with  MRSA  infecXons  or  colonizaXons  before  leaving  the  room    

¤ An  insXtuXonal  campaign  for  promoXng  the  use  of  alcohol-­‐based  hand-­‐rub  soluXons  in  place  of  hand  washing    ² launched  in  2001    ² Training  materials  to  the  infecXon  control  teams  (slide  shows,  200  000  brochures,  and  14  000  posters)  

² formal  leRers  by  the  general  director  asking  all  administrators,  heads  of  departments,  and  chief  nurses  to  support  the  campaign.  

IdenXficaXon  of  MRSA  PaXents    

¤ Passive  surveillance  through  rouXne  clinical  specimens  ¤ AcXve  surveillance  (screening)  by  culturing  nares  of  

paXents  with  a  high  risk  of  MRSA  colonizaXon,  eg,  intensive  care  unit  (ICU)  paXents  and  contacts  of  MRSA  paXents  

¤ Quick  noXficaXon  and  flagging  of  new  paXents  with  MRSA  infecXons  or  colonizaXons  by  laboratories  to  medical  teams    

¤  IdenXficaXon  of  MRSA  paXent  rooms  and  charts  (sXcker)    ¤  Informing  units  to  which  paXents  with  MRSA  are  

transferred.  

Feedback    

¤  Feedback  to  the  local  hospital  community  on  the  results  (MRSA  rates  and  progress  in  program  implementaXon).    

Annual  report  

¤  Each  hospital  reporXng  to  the  central  administraXon  

² size  of  the  infecXon  control  team  

²  implementaXon  of  the  program  

² organizaXon  of  audits  (eg,  on  hand  hygiene)  

²  feed-­‐back    

² progress  of  the  iniXaXve  has  been  annually  presented  during  meeXngs  of  infecXon  control  teams  and  bacteriologists  from  all  AP-­‐HP  hospitals,    

Page 12: MRSA in the Netherlands

MRSA  in  the  NL   01-­‐03-­‐13  

Andreas  Voss,    MD,  PhD   12  

46 7734 41 54 67 97 104 100

229

547

851

705659

854

0

100

200

300

400

500

600

700

800

900

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

No. o

f is

olat

es

Each  person  only  included  once,  unless  a  new  subtype  is  found          R.  Skov  2009  

020406080

100120140160180200220240

1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

No.

of i

sola

tes

Import HA HACO CA

 R.  Skov  2009  71% of the MRSA cases in Copenhagen area were community-onset MRSA (CO-MRSA)  

 ...  lines  between  categories  may  be  “graying,”  with  community-­‐associated  strains  encroaching  on  hospitals,  and  health-­‐care  associated  strains  

entering  the  community.    

Stranden  et  al.    InfecXon  2009;37:44  

v     36.4%  of  11  CA-­‐MRSA  and  43.9%  of  66  HA-­‐MRSA  harbored                SCCmec  type  IV/IVA.  v     Type  IV/IVA  has  become  the  most  common  SCCmec  type  in                inpaXents  of  a  Swiss  university  hospital.    v     SCCmec  type  IV/IVA  is  present  in  both  CA-­‐MRSA  and  HA-­‐MRSA                limiXng  its  use  as  a  marker  for  CA-­‐MRSA.    

¤   we  have  all  kind  of  SSCmec-­‐types  in  the      hospital  (including  IV  and  V)  

¤   we  have  healthcare  outbreaks  of  ST398-­‐MRSA      and  CA-­‐MRSA  strains  

¤   we  have  HA-­‐MRSA  strains  in  the  community,  in      pets  and  in  livestock  animals    

¤   MRSA  -­‐  it’s  not  graying,  it  is  gray!  

Page 13: MRSA in the Netherlands

MRSA  in  the  NL   01-­‐03-­‐13  

Andreas  Voss,    MD,  PhD   13  

CA-­‐MRSA                                                              HA-­‐MRSA                                                  LA-­‐MRSA       CA-­‐MRSA                                                              HA-­‐MRSA                                                  LA-­‐MRSA                                                                                                                Just-­‐MRSA      

¤   We  know  the  risk  factors  for  HA-­‐MRSA  ²   foreign  admission/dialysis,  adopXon,  known        outbreaks,  (nursing  homes)  

¤   We  know  the  risk  factors  for  LA-­‐MRSA  ²   pig-­‐  and  calf-­‐farming  (poultry)  ²   (but  this  may  change)  

¤   We  know  some  of  the  risk  factors  for  CA-­‐MRSA  ²   but  can’t  use  them  for  S&D  

¤   Consequent  decolonizaXon  of  all  MRSA      carriers  (especially  outside  the  hospitals)  is  of      upmost  importance  !  ²   works  with  HA-­‐MRSA  

²   should  work  with  CA-­‐MRSA  

²   trouble  LA-­‐MRSA  

020406080

100120140160180200220240

1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

No.

of i

sola

tes

Import HA HACO CA

 R.  Skov  2009  71% of the MRSA cases in Copenhagen area were community-onset MRSA (CO-MRSA)  

 The  Danish  curbed  this  outbreak  by  ”destroying”  the  community  sources  

 

Page 14: MRSA in the Netherlands

MRSA  in  the  NL   01-­‐03-­‐13  

Andreas  Voss,    MD,  PhD   14  

¤   To  a  certainly  level  it  may  be  the  major      components  that  count  not  the  details:    ²   Good  epidemiology  ²   Screening  ²   IsolaXon  (single  room  and  glove  and  gowns)  ²   Hand  hygiene  ²   CommunicaXon  ²   DecolonizaXon  

While  important  other  factors  count:  

¤   Compliance  with  basic  infecXon  control      measures  in  all  (healthcare)  setngs  

¤   Infrastructure  of  healthcare  setngs  

¤   HCW-­‐paXent/client  raXo  

¤   AnXbioXc  use    

¤   Farming  (!)  &  food  (?)  

¤   PDF  of  b/w  slides  (6  per  page)  at:        hRp://www.slideshare.net/iPrevent/  

June  25-­‐28,  2013  Geneva  Switzerland  

   

www.icpic2013.com  

hRp://www.aricjournal.com/  

“We  appreciate  you  reading  &  ciXng  

ARIC  and  welcome  your  manuscripts”  

“Before  you  criXsize  someone  you  should  walk  a  mile  in  their  shoes  …  

 …  that  way,  if  he  gets  angry,  he'll  be  a  mile  

away,  and  you  have  their  shoes  ”  

Homer  Simpson  “SlideShare  iPrevent”